Please use this identifier to cite or link to this item:
|Title: ||Regulations have improved since thalidomide but drug scares are still possible|
|Authors: ||Lipworth, W|
|Issue Date: ||10-Dec-2015|
|Publisher: ||The Conversation|
|Citation: ||Wendy Lipworth Regulations have improved since thalidomide but drug scares are still possible The Conversation 2015|
|Abstract: ||The thalidomide tragedy, which resulted in thousands of deaths and disabilities in the late 1950s and early 1960s, changed medicine forever. One of its outcomes was the establishment of more robust mechanisms for the regulation of medicines and medical devices.
Regulatory bodies – including the Therapeutic Goods Administration (TGA) in Australia, the Food and Drug Administration (FDA) in the United States and the Medicines and Health care products Regulatory Agency (MHRA) in the United Kingdom – now decide which products pharmaceutical and medical device companies can market. They also monitor the safety of medicines and devices once they are on the market.
There is no doubt that the tightening of regulation has prevented countless deaths and disabilities, and saved many lives. But regulation cannot always protect us from harm and events disturbingly similar to the thalidomide tragedy continue to occur. Let’s look at two recent examples.|
|Description: ||the Conversation article|
|Type of Work: ||Article|
|Appears in Collections:||Research Papers and Publications. Sydney Health Ethics|
This work is protected by Copyright. All rights reserved. Access to this work is provided for the purposes of personal research and study. Except where permitted under the Copyright Act 1968, this work must not be copied or communicated to others without the express permission of the copyright owner. Use the persistent URI in this record to enable others to access this work.
|TheConv_regulations-have-improved-2015.pdf||339.91 kB||Adobe PDF|
Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.